<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Garcinia kola</italic> (bitter kola) is widely used in TAM, the West African sub-region in particular, for a host of conditions including infectious diseases and management of upper respiratory infections (
 <xref rid="B38" ref-type="bibr">Buba et al., 2016</xref>). GARCINIA-IHP, used for symptoms of cold and sore throat, pains, cough, nasal congestion, viral infections and inflammation, is one of the herbal health products marketed by InterceDD Health Products in Nigeria. This herbal formulation is currently under consideration as a repurposed remedy in COVID-19 management after successful clinical trials. As a result of the radical media promotion of claims on 
 <italic>Garcinia kola</italic> in COVID-19 prevention and management which lacks scientific evidence, the seed of the plant has become one of the many other local herbal recipes consumed without any control by a majority of people in West Africa. The correct doses of bitter kola to achieve the best therapeutic effects and without any adverse side effects are often not followed. However, scientific report suggests that 
 <italic>Garcinia kola</italic> induces CYP3A4 transcription by a multiple of 3.7-factors in HepG2 cells at 90 μmol/L (
 <xref rid="B199" ref-type="bibr">Nwankwo et al., 2000</xref>) increasing the possibility for herb-drug interaction. Future investigations will therefore focus on the extensive 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> anti-SARS CoV-2 activities of extracts of 
 <italic>Garcinia kola</italic>, in depth toxicity studies and a holistic investigation of a possible herb-drug interaction.
</p>
